Parkinson's disease (PD) is characterized mainly by motor dysfunctions due to the
progressive loss of dopaminergic neurons. However, PD patients experience a multitude of …

The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

Objective To determine whether, for patients with depression and Parkinson disease (PD),
telephone-based cognitive-behavioral treatment (T-CBT) alleviates depressive symptoms …

Abstract Depression in Parkinson's Disorder (DPD) has been estimated to appear in up to
40% of people with PD and negatively impacts quality of life, motor and cognitive deficits …

Neurodegenerative disorders exhibit considerable clinical heterogeneity and are frequently
misdiagnosed. This heterogeneity is often neglected and difficult to study. Therefore …

Problematic gambling has been suggested to be a possible consequence of dopaminergic
medications used mainly in neurological conditions, ie pramipexole and ropinirole, and …

Depression and anxiety are highly prevalent in most neurological disorders and can have a
major impact on the patient's disability and quality of life. However, mostly due to the …

Objective To determine the evolution of numerous neuropsychiatric symptoms and cognitive
abilities in Parkinson disease from disease onset. Methods Prospectively collected …

Background Depression and anxiety are non-motor symptoms of Parkinson's disease (PD)
that are often overlooked and underrated. This study aimed to highlight the frequency and …

Background The psychological impact of the COVID-19 outbreak and lockdown on frail
populations with advanced Parkinson disease (APD) and their caregivers may present with …